BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Deals

  Neumora Explodes onto Neuro Scene with $500 Million and Amgen Alliance

  Fresh out of the gates with $500 million in financing, Neumora Therapeutics forged a partnership with Amgen to develop and commercialize assets for neurodegenerative diseases.

  October 7, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Intergalactic Therapeutics Launches with $75 Million Series A

  Intergalactic Therapeutics closed on a Series A funding round worth $75 million. The company was launched by Advanced Technology Products Corporation (ATP).

  October 7, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  UBS Hands Over $650 Million to Life Sciences Impact Investment Fund

  Funding in the life sciences has been running rampant so far this year, with billions of dollars being funneled to companies from investors.

  October 7, 2021

   · 

  2 min read

   · 

  Ellen Camacho
• 

  Drug Development

  What Offers Better Protection from COVID-19: Previous Infection or Vaccination?

  The question is continually being raised: what offers superior protection, a vaccine against COVID-19 or natural immunity?

  October 7, 2021

   · 

  3 min read

   · 

  Vanessa Doctor, RN
• 

  Policy

  Ginkgo Bioworks Hit After Short Seller Claims Business Model a ‘Shell Game’

  Litigator Block & Leviton is launching an investigation into Ginkgo Bioworks after short seller Scorpion Capital released a report alleging that Ginkgo is running a fraudulent operation.

  October 7, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Another Pfizer Exec Lines Up Retirement After COVID-19 Vaccine Mega-Win

  Pfizer’s exec team is hit with a double whammy as another c-suite leader announces his retirement.

  October 7, 2021

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Career Advice

  How to Handle Workplace Issues Directly

  Workplace issues can arise anytime so it is always better to be prepared to seek out the problems directly in a mannered way to avoid any kind of personal rivalry.

  October 7, 2021

   · 

  5 min read

   · 

  Karen Walpole
• 

  Business

  BioSpace Movers & Shakers, Oct. 8

  Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

  October 7, 2021

   · 

  11 min read

   · 

  Alex Keown
• 

  Business

  Stakeholder Collaborations Essential to Making Things Happen in Rare Disease Space

  Patients and patient organizations, which have detailed insights in the natural history of a rare disease, should be integral, too.

  October 7, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Drug Development

  Denali Moving Forward with Sanofi-Partnered ALS Candidate

  Denali Therapeutics reported positive Phase I data and regulatory progress for two therapeutics for ALS at the virtual 2021 Annual Northeast ALS Meeting.

  October 7, 2021

   · 

  3 min read

   · 

  Mark Terry